← Back to Screener
The Cigna Group (CI)
Price$279.92
Favorite Metrics
Price vs S&P 500 (26W)-16.09%
Price vs S&P 500 (4W)-3.48%
Market Capitalization$73.58B
P/E Ratio (Annual)12.35x
Indicated Dividend Yield (Annual)2.24%
All Metrics
P/CF (Annual)7.66x
Book Value / Share (Quarterly)$158.33
P/TBV (Annual)5.59x
Indicated Dividend (Annual)$6.04
Revenue Growth (3Y)15.05%
Cash Flow / Share (Quarterly)$31.84
Payout Ratio (TTM)27.04%
Price vs S&P 500 (YTD)-2.90%
Gross Margin (TTM)9.30%
Net Profit Margin (TTM)2.17%
EPS (TTM)$22.13
10-Day Avg Trading Volume1.26M
EPS Excl Extra (TTM)$22.13
Revenue Growth (5Y)11.40%
EPS (Annual)$22.18
Dividend / Share (Annual)$6.00
ROI (Annual)8.14%
Gross Margin (Annual)9.30%
Net Profit Margin (5Y Avg)2.59%
Cash / Share (Quarterly)$33.14
P/E Basic Excl Extra (TTM)12.35x
Revenue Growth QoQ (YoY)10.39%
EPS Growth (5Y)-0.71%
P/E Normalized (Annual)12.35x
ROA (Last FY)3.77%
Revenue Growth TTM (YoY)11.24%
EBITD / Share (TTM)$40.64
ROE (5Y Avg)12.03%
Operating Margin (TTM)3.35%
Cash Flow / Share (Annual)$31.84
P/B Ratio1.76x
P/B Ratio (Quarterly)1.76x
Net Income / Employee (Annual)$0
EV / Revenue (TTM)0.35x
Net Interest Coverage (TTM)6.43x
ROA (TTM)3.85%
EPS Growth QoQ (YoY)-11.30%
EV / EBITDA (TTM)8.89x
EPS Incl Extra (Annual)$22.18
Current Ratio (Annual)0.85x
Quick Ratio (Quarterly)0.72x
3-Month Avg Trading Volume1.67M
52-Week Price Return-15.42%
EV / Free Cash Flow (Annual)11.61x
P/E Incl Extra (TTM)12.35x
Revenue / Employee (TTM)$4
Tangible BV / Share (Quarterly)$49.92
P/S Ratio (Annual)0.27x
Asset Turnover (Annual)1.74x
52-Week High$350.00
Operating Margin (5Y Avg)4.15%
EPS Excl Extra (Annual)$22.18
CapEx CAGR (5Y)2.07%
Tangible BV CAGR (5Y)-2.78%
26-Week Price Return-7.35%
Quick Ratio (Annual)0.72x
13-Week Price Return2.82%
Total Debt / Equity (Annual)0.75x
Current Ratio (Quarterly)0.85x
Enterprise Value$97,366.36
Revenue / Share Growth (5Y)18.65%
Asset Turnover (TTM)1.78x
Book Value / Share Growth (5Y)2.24%
Revenue / Employee (Annual)$4
Inventory Turnover (Annual)35.54x
Pretax Margin (Annual)2.83%
Cash / Share (Annual)$33.14
3-Month Return Std Dev27.64%
Gross Margin (5Y Avg)11.78%
Net Income / Employee (TTM)$0
EBITDA CAGR (5Y)-4.97%
EBITDA Interim CAGR (5Y)-15.08%
ROE (Last FY)14.28%
Net Interest Coverage (Annual)6.43x
EPS Basic Excl Extra (Annual)$22.18
P/FCF (TTM)6.97x
Receivables Turnover (TTM)10.37x
EV / Free Cash Flow (TTM)11.61x
Total Debt / Equity (Quarterly)0.75x
EPS Incl Extra (TTM)$22.13
Receivables Turnover (Annual)10.37x
ROI (TTM)8.20%
Dividend Growth Rate (5Y)170.91%
P/S Ratio (TTM)0.27x
Pretax Margin (5Y Avg)3.26%
Revenue / Share (Annual)$1023.60
Tangible BV / Share (Annual)$49.92
Forward P/E9.24x
Free OCF CAGR (5Y)-1.95%
Price vs S&P 500 (52W)-50.52%
P/E Ratio (TTM)12.35x
EPS Growth TTM (YoY)80.88%
Year-to-Date Return1.24%
5-Day Price Return1.28%
EPS Normalized (Annual)$22.18
ROA (5Y Avg)3.49%
Net Profit Margin (Annual)2.17%
Month-to-Date Return4.46%
Cash Flow / Share (TTM)$28.27
EBITD / Share (Annual)$40.79
EPS Growth (3Y)1.35%
Operating Margin (Annual)3.35%
LT Debt / Equity (Annual)0.74x
P/CF (TTM)7.66x
ROI (5Y Avg)6.99%
P/E Excl Extra (TTM)12.35x
LT Debt / Equity (Quarterly)0.74x
EPS Basic Excl Extra (TTM)$22.13
P/TBV (Quarterly)5.59x
Payout Ratio (Annual)27.04%
P/B Ratio (Annual)1.76x
Dividend / Share (TTM)$6.00
Inventory Turnover (TTM)35.54x
Pretax Margin (TTM)2.83%
Book Value / Share (Annual)$158.33
Price vs S&P 500 (13W)-0.05%
Net Margin Growth (5Y)-16.29%
Dividend Yield (TTM)2.19%
Beta0.28x
P/FCF (Annual)8.77x
Revenue / Share (TTM)$1013.09
ROE (TTM)14.53%
52-Week Low$239.51
Analyst Recommendations
Jan 2026
Feb 2026
Mar 2026
Apr 2026
4.12
4.12
4.12
4.18
Industry Peers — Hospital & Medical Insurance(9)
| Symbol | P/B Ratio (Quarterly) | ROE (TTM) | Indicated Dividend Yield (Annual) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|
CIThe Cigna Group | 1.76x | 14.53% | 2.24% | 3.35% | $279.92 |
UNHUNITEDHEALTH GROUP INCORPORATED (Delaware) | 2.99x | 12.50% | 2.73% | 4.18% | $323.48 |
ELVElevance Health, Inc. | 1.78x | 13.01% | 2.13% | 4.07% | $319.36 |
HUMHumana Inc. | 1.74x | 6.59% | 1.68% | 2.03% | $210.34 |
CNCCentene Corporation | 1.01x | -27.74% | — | -3.91% | $38.31 |
MOHMolina Healthcare, Inc. | 2.19x | 10.99% | — | 1.72% | $150.12 |
OSCROscar Health, Inc. | 3.89x | -39.45% | — | -3.39% | $16.44 |
ALHCAlignment Healthcare, Inc. Common Stock | 22.04x | -0.49% | — | 0.37% | $21.56 |
TRUPTrupanion, Inc. | 4.20x | 5.39% | — | 0.98% | $28.88 |
CLOVClover Health Investments, Corp | 3.93x | -25.73% | — | -4.44% | $2.23 |
About
Cigna is a diversified healthcare company providing pharmacy benefit management (PBM) and health insurance services, primarily to employers and health plans. The company significantly expanded its PBM and specialty pharmacy operations through its 2018 acquisition of Express Scripts, resulting in a member base of 17 million US and 2 million international enrollees as of December 2024. Cigna's PBM business includes a major Department of Defense contract through 2029 and a recent multiyear agreement with Centene, while its health insurance segment primarily serves employers through self-funded arrangements.